CAS: 51-52-5; 6-Propyl-2-Thioxo-2,3-Dihydropyrimidin-4(1H)-One

该化合物是一种抗甲状腺药物,主要用于管理超甲状腺病,特别是在格雷夫氏病等条件下;它的作用是抑制对甲状腺过氧化酶酶,这对甲状腺激素合成至关重要,从而减少其产量;PTU是白白的,脱白的晶状粉,在水中略有溶解,在有机溶剂中更易溶解;其分子配方为C7H10N2OS,其分子重量约为170.24克/摩尔;该化合物已知,因为它能够跨越胎盘,有时用于孕妇治疗甲状腺病,尽管由于潜在的副作用,人们告诫要谨慎行事;常见的副作用包括:皮质,肝毒性和腺囊病,需要在治疗期间定期监测血量;丙基希诺酸通常以口头方式施用,并且以平板形式提供.其血清反应涉及快速吸收和相对短的半衰期,需要每天多剂量来有效管理甲状腺激素.

结构式图片

相似化合物

56-04-2 53939-84-7 53939-83-6

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号30414-54-1 丁酰乙酸甲酯 | CAS号3249-68-1 丁酰乙酸乙酯 | CAS号28267-45-0 1,3-dimethyl-6-... | CAS号13345-08-9 6-丙基嘧啶-2,4(1H,3H)-二酮 | CAS号16290-54-3 5-bromo-6-propy... | CAS号79134-19-3 2-(5-nitropyrid... | CAS号79932-97-1 3-(5-nitropyrid... | CAS号89938-07-8 2,6-二氯-4-正丙基嘧啶 | CAS号53760-57-9 2-benzylsulfany...

合成工艺路线路线简述

  • 合成目标产物 Propylthiouracil 主要起始原料 Carbamimidothioic Acid And Methyl 3-Oxohexanoate
  • (文献来源)合成步骤主要原料 Carbamimidothioic Acid 和 Methyl 3-Oxohexanoate
在 溶剂黄146体系中,用 水 作为反应溶剂,化学反应 1.0H,反应生成 丙硫氧嘧啶
参考文献: 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives[fr] Derives 4-Phenyle-Pyrimidine-2-Carbonitrile
标题: 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives[fr] Derives 4-Phenyle-Pyrimidine-2-Carbonitrile
摘要:该发明涉及具有通式(i)或其药学上可接受的盐的4-苯基嘧啶-2-羰基衍生物.该发明还涉及包含上述衍生物的药物组合物,以及在制备适用于治疗骨质疏松症,动脉粥样硬化,炎症和免疫性疾病(如类风湿性关节炎)以及神经病理性疼痛(如神经病性疼痛)的药物中的使用.

海关参考信息

专利信息


专利号:US-8754058-B2
优先权日:2009-09-29
标 题:Inhibitors of FAM3B gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals
发明人:GUAN YOUFEI; LIANG ZICAI
权利人:GUAN YOUFEI; LIANG ZICAI; SUZHOU RIBO LIFE SCIENCE COMPANY LTD
摘要:Inhibitors that can inhibit expression of FAM3B gene to reduce the levels of expression products, or can combine the expression products to reduce the activity of promoting lipid synthesis of FAM3B gene product are provided, wherein the inhibitors are one or more inhibitors selected from the group consisting of small interfering RNAs, antisense oligonucleotides, antibodies against FAM3B proteins and active organic compounds. Cells, vectors or inhibitor compositions, comprising such inhibitors, methods for inhibiting expression of FAM3B gene or inhibiting the activity of promoting lipid synthesis of FAM3B gene product using the inhibitors are provided. Methods for treating diseases mediated by expression of FAM3B gene using such inhibitors and uses of the inhibitors in preparing pharmaceuticals for preventing and/or treating the disease mediated by FAM3B gene expression are also provided.

专利号:EP-1382327-A1
优先权日:2002-07-17
标 题 :Method of protection of the skin against ageing
发明人:DANOUX LOUIS; FREIS OLGA; PAULY GILLES
权利人:COGNIS FRANCE SA
摘要:A method for the production of means for the stimulation of human is proposednSkin cells as well as to protect against skin aging and damaging influencesnEnvironmental toxins and UV radiation, characterized in that the means at least onenSubstance containing the synthesis of energy donors of the mitochondrial respiratory chainnincreases while at the same time the rate of reactive oxygen species (ROS) innCell metabolism lowers.n n n Furthermore, the use of cosmetic and / or pharmaceutical preparations,ncontaining at least one substance which the synthesis of energy donorsnthe mitochondrial respiratory chain increases while at the same time the rate of reactive oxygen speciesn(ROS) in cell metabolism, to stimulate human skin cellsnas well as to the protection against skin aging and damaging influences by environmental poisons andnUV radiation proposed.

专利号:US-10799441-B2
优先权日:2011-06-06
标题:Skin treatments containing pyrroloquinoline quinone (PQQ) esters and methods of preparation and use thereof
发明人:LEWIS II JOSEPH ABERNATHY; DINARDO JOSEPH C
权利人:LEWIS II JOSEPH ABERNATHY; DINARDO JOSEPH C; PCR TECH HOLDINGS LC
摘要:The present invention relates to cosmetic or dermatological compositions containing PQQ or its esters, methods of treating or promoting skin changes by topical application of these compositions, and methods of synthesis of PQQ esters. The PQQ ester-containing compositions of the present invention are unexpectedly effective in treating skin, particularly with respect to skin tolerance. When included in a topical composition, the PQQ esters of the present invention have an antioxidant effect that is useful in treating a skin change.

专利号:US-2005080260-A1
优先权日:2003-04-22
标 题 :Preparation of prodrugs for selective drug delivery
发明人:MILLS RANDELL L; WU GUO-ZHANG
摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

专利号:US-8378072-B2
优先权日:2006-04-13
标题 :Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
发明人:BONNIN DUSTAN
权利人:DECLION PHARMACEUTICALS INC; BONNIN DUSTAN
摘要:The instant invention comprises a process for the solid phase synthesis of directed epitope peptide mixtures useful in the modulation of unwanted immune responses, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. The resulting composition is a mixture of related peptides for therapeutic use.

专利号:US-11773060-B2
优先权日:2016-05-25
标题 :Method for synthesis of 9-cis-beta-carotene and formulations thereof
发明人:GAZIT EHUD; BUZHANSKY LUDMILA; IOFFE MICHAEL; SAYER ALON
权利人:UNIV RAMOT
摘要:A formulation includes an active agent, a thickening/solidifying agent, and an antioxidant. The active agent is 9-cis-β-carotene (9CBC) or a derivative thereof of the following formula:where R2 is H or methyl; X isoptionally substituted with one or more methyl groups; n is an integer of 0-16; and the asterisk represents the point of attachment to the cyclohexene ring.
台州开创生物医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.creatingbiopharm.com
企业联系电话:0576-88827176;18906581668👤
📞台州开创生物医药有限公司 ⚠️参考联系方式
联系人:余美平
电话:0576-88827176;18906581668
手机:13586099526;18906581668
传真:0576-88822496
邮箱:sales@creatingbiopharm.com
通信地址: 浙江省台州市君悦大厦A幢715
邮编: 318000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省台州市君悦大厦A幢715
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
南通长三角化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.ntcsjhg.cn
企业联系电话:0513-85537869👤
📞南通长三角化工有限公司 ⚠️参考联系方式
联系人:陈先生;马先生
电话:0513-85537869
手机:13901473920;13921680597

邮箱:ntchangsanjiao@163.com
通信地址: 南通市开发区创业外包中心 D座3层
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:南通市开发区创业外包中心 D座3层
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
台州荃力科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.quick-chemical.com
企业联系电话:+86-576-88780728👤
📞台州荃力科技有限公司 ⚠️参考联系方式
联系人:陶经理
电话:+86-576-88780728
手机:18968528007
传真:+86-576-88783258
邮箱:sales@quick-chemical.com
通信地址: 浙江省台州市椒江区君悦大厦B幢732室
邮编: 318000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省台州市椒江区君悦大厦B幢732室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
苏州恒益医药原料有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.szhengyi.com
企业联系电话:0512-57663281;18913251393👤
📞苏州恒益医药原料有限公司 ⚠️参考联系方式
联系人:王经理
电话:0512-57663281;18913251393
手机:18913251393
传真:0512-57665666
邮箱:18913251393@189.cn
通信地址: 江苏省太仓市城厢镇上海东路188号 万达广场写字楼B座706室
邮编: 215400
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省太仓市城厢镇上海东路188号 万达广场写字楼B座706室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
武汉华玖医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.whhjpharm.com
企业联系电话:18120446293👤
📞武汉华玖医药科技有限公司 ⚠️参考联系方式
联系人:汪经理
电话:18120446293
手机:18120446293
传真:027-59220200
邮箱:3504472216@qq.com
通信地址: 武汉市东西湖区泾河办事处陈家岭189号
邮编: 432000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:武汉市东西湖区泾河办事处陈家岭189号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Duan Q, Wang T, Zhang N, Perera V, Liang X, Abeysekera IR, Yao X. Propylthiouracil, Perchlorate, and Thyroid-Stimulating Hormone Modulate High Concentrations of Iodide Instigated Mitochondrial Superoxide Production in the Thyroids of Metallothionein I/II Knockout Mice. Endocrinol Metab (Seoul). 2016 Mar;31(1):174-84. doi: 10.3803/EnM.2016.31.1.174.
2: Ben Hamida F, Troudi A, Sefi M, Boudawara T, Zeghal N. The protective effect of propylthiouracil against hepatotoxicity induced by chromium in adult mice. Toxicol Ind Health. 2016 Feb;32(2):235-45. doi: 10.1177/0748233713498446. Epub 2013 Sep 30. doi: 10.1177/0748233713491799. Epub 2013 May 30. doi: 10.1093/rheumatology/kev243. Epub 2015 Jul 10. pii: 13030/qt3v22b88d. doi: 10.1007/s40618-015-0281-z. Epub 2015 Apr 4. doi: 10.4103/0972-5229.162471.
9: Bagnato G, Bitto A, Pizzino G, Roberts WN, Squadrito F, Altavilla D, Bagnato G, Saitta A. Propylthiouracil modulates aortic vasculopathy in the oxidative stress model of systemic sclerosis. Vascul Pharmacol. 2015 Aug;71:79-83. doi: 10.1016/j.vph.2014.12.006. Epub 2015 Apr 11. doi: 10.1177/1534734614549418. Epub 2014 Sep 25. doi: 10.1074/jbc.M114.629964. Epub 2015 May 22.

合成参考文献


参考文献:10.1186/1476-069x-10-65
摘要:Hayley S, Mangano E, Crowe G, Li N, Bowers WJ. An in vivo animal study assessing long-term changes in hypothalamic cytokines following perinatal exposure to a chemical mixture based on Arctic maternal body burden. Environmental Health. 2011 Jul 11;10(1):65. doi: 10.1186/1476-069x-10-65.
摘要:Sabnis GR, Karnik ND, Chavan SA, Korivi DS, Pati MV. Trauma precipitating thyroid storm. J Assoc Physicians India. 2011 Feb;59():117–9.
参考文献:10.1155/2011/647168
摘要:Gati D, Vieira AR. Elderly at Greater Risk for Root Caries: A Look at the Multifactorial Risks with Emphasis on Genetics Susceptibility. International Journal of Dentistry. 2011;2011():1–6. doi: 10.1155/2011/647168.
参考文献:10.1155/2011/306069
摘要:Ozsoy Y, Ozsoy M, Coskun T, Yavuz K, Ozbilgin K, Namlı K, Var A, Ozyurt B. The effects of L-arginine on liver damage in experimental acute cholestasis an immunohistochemical study. HPB Surg. 2011;2011():306069.
参考文献:10.1155/2011/390916
摘要:Makol A, Watt KD, Chowdhary VR. Autoimmune Hepatitis: A Review of Current Diagnosis and Treatment. Hepatitis Research and Treatment. 2011 May 15;2011():1–11. doi: 10.1155/2011/390916.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知